Hospital-acquired and ventilator-related pneumonia get a 7-day course, IDSA says.
Saudi Arabia's Ministry of Health (MOH) reported a new case of MERS-CoV today that is not related to the current outbreak that began at the King Khalid University Hospital in Riyadh.
The MOH said a 86-year-old Saudi man from Al Aflaj is in stable condition after having symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus). This is the second case since May in Al Aflaj, located in the central part of the country.
The Centers for Disease Control and Prevention (CDC) is recommending clinicians and all patient populations stop using the liquid stool softener docusate after the medicine has been implicated in an ongoing, healthcare-related Burkholderia cepacia complex (B cepacia) outbreak.
Feds say coordinated activities can save $1 billion a year.
Following the development of a rapid diagnostic test for multidrug-resistant tuberculosis (MDR-TB) strains, the World Health Organization (WHO) today recommended a shorter treatment regimen for patients with uncomplicated MDR-TB infections.
A report by CBS's 60 Minutes yesterday alleged that the US company Halyard Health for years sold surgical gowns that it knew were defective, putting healthcare workers at risk for bloodborne infections. In a press release today, the company strongly denied the allegations
A case-study series from the Pew Charitable Trusts profiles the impact of antibiotic stewardship programs, which also include cost savings.
NewLink Genetics Corporation announced yesterday that it had received $21.6 million in federal funding to continue developing its vesicular stomatitis virus–Ebola virus (VSV-EBOV) vaccine candidate.
Pet dogs and cats can be colonized with the MCR-1 antibiotic-resistance gene and pass it to people, Chinese researchers reported yesterday in a letter to Emerging Infectious Diseases. Their findings came from an investigation into MCR-1–harboring Escherichia coli isolates from three men hospitalized in a Guangzhou facility's urology ward toward the end of 2015.
Exceptional Ebola surveillance and swift responses to outbreaks will be the key to taking advantage of the availability of Ebola vaccines, say three experts who offered their thoughts on the future use of such vaccines in a new article from the World Health Organization (WHO).
